Carsten Magnus
Carsten Magnus
F. Hoffmann-La Roche
Verified email at roche.com - Homepage
Title
Cited by
Cited by
Year
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
P Rusert, A Krarup, C Magnus, OF Brandenberg, J Weber, AK Ehlert, ...
Journal of Experimental Medicine 208 (7), 1419-1433, 2011
1042011
Estimating the stoichiometry of human immunodeficiency virus entry
C Magnus, P Rusert, S Bonhoeffer, A Trkola, RR Regoes
Journal of virology 83 (3), 1523-1531, 2009
1022009
Determinants of HIV-1 broadly neutralizing antibody induction
P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ...
Nature medicine 22 (11), 1260, 2016
892016
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry
OF Brandenberg, C Magnus, P Rusert, RR Regoes, A Trkola
PLoS pathogens 11 (1), 2015
652015
Modelling the course of an HIV infection: insights from ecology and evolution
S Alizon, C Magnus
Viruses 4 (10), 1984-2013, 2012
632012
Classic reaction kinetics can explain complex patterns of antibiotic action
P Abel zur Wiesch, S Abel, S Gkotzis, P Ocampo, J Engelstädter, ...
Science Translational Medicine 7 (287), 287ra73, 2015
522015
Capacity of broadly neutralizing antibodies to inhibit HIV-1 cell-cell transmission is strain-and epitope-dependent
L Reh, C Magnus, M Schanz, J Weber, T Uhr, P Rusert, A Trkola
PLoS pathogens 11 (7), 2015
472015
The HIV-1 entry process: a stoichiometric view
OF Brandenberg, C Magnus, RR Regoes, A Trkola
Trends in microbiology 23 (12), 763-774, 2015
392015
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs
CS Oberle, B Joos, P Rusert, NK Campbell, D Beauparlant, H Kuster, ...
Retrovirology 13 (1), 62, 2016
362016
Estimating the stoichiometry of HIV neutralization
C Magnus, RR Regoes
PLoS computational biology 6 (3), 2010
362010
Taming the BEAST—A community teaching material resource for BEAST 2
J Barido-Sottani, V Bošková, LD Plessis, D Kühnert, C Magnus, V Mitov, ...
Systematic biology 67 (1), 170-174, 2018
232018
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
OF Brandenberg, C Magnus, P Rusert, HF Günthard, RR Regoes, ...
PLoS pathogens 13 (5), 2017
212017
Restricted occupancy models for neutralization of HIV virions and populations
C Magnus, RR Regoes
Journal of Theoretical Biology 283 (1), 192-202, 2011
212011
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain’s exceptional capacity for sequence variation
OF Brandenberg, P Rusert, C Magnus, J Weber, J Böni, HF Günthard, ...
Retrovirology 11 (1), 75, 2014
182014
Delineating CD4 dependency of HIV-1: adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
D Beauparlant, P Rusert, C Magnus, C Kadelka, J Weber, T Uhr, ...
PLoS pathogens 13 (3), e1006255, 2017
172017
Analysis of the subunit stoichiometries in viral entry
C Magnus, RR Regoes
PLoS One 7 (3), 2012
152012
The influence of phylodynamic model specifications on parameter estimates of the Zika virus epidemic
V Boskova, T Stadler, C Magnus
Virus evolution 4 (1), vex044, 2018
142018
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution
C Magnus, L Reh, A Trkola
Virus research 218, 57-70, 2016
102016
Virus neutralisation: new insights from kinetic neutralisation curves
C Magnus
PLoS computational biology 9 (2), 2013
102013
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage
L Reh, C Magnus, C Kadelka, D Kühnert, T Uhr, J Weber, L Morris, ...
PLoS pathogens 14 (1), e1006825, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20